Searched over 200M research papers
7 papers analyzed
These studies suggest that the symptoms of central sleep apnea include cessation of breathing during sleep, sleep disruption, and impaired quality of life.
18 papers analyzed
Central sleep apnea (CSA) is a sleep disorder characterized by the cessation of breathing during sleep due to a lack of respiratory effort. Unlike obstructive sleep apnea, which is caused by physical blockages in the airway, CSA is primarily due to a failure in the brain's respiratory control centers. This condition can lead to significant health issues, including cardiovascular problems and impaired quality of life.
Cessation of Breathing: CSA is marked by frequent episodes of stopped breathing during sleep due to a lack of respiratory drive from the central nervous system .
Daytime Sleepiness and Fatigue: Patients with CSA often experience excessive daytime sleepiness and fatigue due to disrupted sleep patterns .
Neurocognitive Dysfunction: CSA can lead to neurocognitive issues, including problems with attention, memory, and executive function.
Cardiovascular Complications: There is an increased risk of cardiovascular issues, such as heart failure, in patients with CSA .
Disturbed Sleep and Insomnia: CSA often results in disturbed sleep, leading to insomnia and frequent awakenings during the night .
Headaches and Depression: Symptoms such as morning headaches and depression are common among CSA patients .
Hypercapnia and Hypoxemia: CSA can cause abnormalities in gas exchange, leading to hypercapnia (elevated CO2 levels) and hypoxemia (low oxygen levels) .
Snoring and Gasping for Air: Although less common than in obstructive sleep apnea, some CSA patients may experience snoring and gasping for air .
Central sleep apnea is a serious sleep disorder characterized by the cessation of breathing due to a lack of respiratory effort. Key symptoms include daytime sleepiness, neurocognitive dysfunction, cardiovascular complications, disturbed sleep, headaches, and gas exchange abnormalities. Effective diagnosis and treatment are crucial for improving the quality of life and reducing the risk of severe health complications in CSA patients.
Most relevant research papers on this topic